Q1 FDA warning letter roundup with Asa Waldstein
Asa Waldstein
Mar 1, 2022
In his quarterly update, consultant Asa Waldstein identifies trends in FDA warning letters impacting manufacturers and marketers of dietary supplements.
Asa Waldstein
Mar 1, 2022
In his quarterly update, consultant Asa Waldstein identifies trends in FDA warning letters impacting manufacturers and marketers of dietary supplements.